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Introduction. The objective of this paper is the comparison 
between two different technologies used for the removal of a uter-
ine myoma, a frequent benign tumor: the standard technology cur-
rently used, laparoscopy, and an innovative one, colpoceliotomy. 
It was considered relevant to evaluate the real and the potential 
effects of the two technologies implementation and, in addition, 
the consequences that the introduction or exclusion of the innova-
tive technology would have for both the National Health System 
(NHS) and the entire community. 
Methods. The comparison between these two different technolo-
gies, the standard and the innovative one, was conducted using 
a Health Technology Assessment (HTA). In particular, in order 
to analyse their differences, a multi-dimensional approach was 
considered: effectiveness, costs and budget impact analysis data 
were collected, applying different instruments, such as the Activ-
ity Based Costing methodology (ABC), the Cost-Effectiveness 
Analysis (CEA) and the Budget Impact Analysis (BIA). Organisa-
tional, equity and social impact were also evaluated.
Results. The results showed that the introduction of colpoceliot-
omy would provide significant economic savings to the Regional 
and National Health Service; in particular, a saving of € 453.27 
for each surgical procedure. 
Discussion. The introduction of the innovative technology, colpoce-
liotomy, could be considered a valuable tool; one offering many 
advantages related to less invasiveness and a shorter surgical pro-
cedure than the standard technology currently used (laparoscopy).
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Summary
Introduction
Uterine myoma is the most common benign tumour of 
the uterus [1], affecting around 20-25% of women over 
30 years old [2]. The incidence of this disease increases 
from age 40 to 50. 
This disease is usually asymptomatic; sometimes, how-
ever, it may cause disorders such as dysmenorrhea, com-
promising women’s health and quality of life. Symptoms 
may be severe enough to require treatment.
There are several options for the treatment of myomas, 
including both medication and surgical procedures, such 
as myomectomy and hysterectomy. Surgical and other 
invasive interventions still dominate treatment [3], while 
the medical therapy is currently limited to the preopera-
tive reduction of symptoms [4].
Myomectomy is the only surgical option for women of 
childbearing age. With myomectomy, it is necessary to 
consider both laparoscopy and colpoceliotomy, which, 
in this paper, is defined as “innovative technology”.
Laparoscopy was first described by Semns in 1980 [5]. 
It is a surgical procedure in which a small incision is 
made, through which a viewing tube (laparoscope) is in-
serted. Colpoceliotomy is a surgical procedure in which 
an opening of the pelvic cavity is made through the for-
nix of the vagina. The latter procedure is less invasive 
than the standard one; there is no need of any abdomi-
nal incision and the peritoneum is surgically opened via 
the vaginal fornix; furthermore colpoceliotomy can be 
useful even in case of large, numerous and intramural 
fibroids [6]. However, although the first description of 
this method dating from 1951, thanks to De Bedoya [7], 
it is an uncommon methodology as it requires a detailed 
knowledge of the vaginal apparatus and manual trans-
vaginal skills. It is, therefore, a rarely used technique in 
the removal of uterine myomas. Over the last decades, 
this methodology has been studied by other authors [8-
9], asserting that its surgical access to pelvis and, in 
general, its surgical time are more rapid if compared 
with laparoscopy one. However, despite these advan-
tages, gynecologists do not often use vaginal myomec-
tomy [10].
The aim of the present study is to compare laparoscopy 
with colpoceliotomy, focusing on the advantages and 
benefits of the innovative technology, based on their 
use in the Department of Obstetrics and Gynecology of 
the Health Authority Civil Hospital of Legnano. The fi-
nal goal of the analysis conducted is the definition of 
the best procedure to be implemented and used in this 
specific setting, in accordance with a multidimensional 
and multi-disciplinary Health Technology Assessment 
(HTA) approach, considering the Health Authority point 
of view.
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Materials and methods
In order to achieve the above mentioned objective, HTA 
was considered the most acknowledged tool for being 
adopted in the decision-making phase, in professional 
and knowledge-intensive settings, such as hospitals.
HTA is a multi-disciplinary tool, one that aims at evalu-
ating both the real and the potential effects of technolo-
gies, and the consequences that the introduction or the 
exclusion of a procedure has for the health system, the 
economy and society.
The present approach is able to analyse different tech-
nologies, by examining their economic, social, clini-
cal, ethical and organizational implications  [11], thus 
identifying methodologies that offer a greater benefit to 
the population. The primary objective of HTA, is not 
to increase specialists and evaluators’ knowledge, but 
to directly influence the decision making process [12], 
with an evidence-based, more quantitative and objective 
approach.
The present paper compares laparoscopy with colpoceli-
otomy through the implementation of a Hospital-Based 
HTA, namely IMPAQHTA model (Implementation of 
a quick Hospital-based HTA), assuming the Health Au-
thority Civil Hospital of Legnano perspective.
The proposed IMPAQHTA framework was redesigned, 
based on exiting models: 1) Core Model [13], because 
of the completeness of its dimensions; 2) Multi Crite-
ria Decision Analysis  [14], because of the quantitative 
scoring methods evaluation; 3) Lombardy Region Mod-
el [15], because of its alignment with policies, laws and 
country-oriented setting.
The IMPAQHTA framework  [16] identified 8 dimen-
sions to be used in the assessment phase: i) general rel-
evance; ii) safety; iii) efficacy; iv) effectiveness; v) eco-
nomic and financial impact; vi) equity; vii) legal, social 
and ethic impact; and viii) organizational impact. The 
above mentioned dimensions could be evaluated using 
13 specific quantitative metrics.
The implemented framework is composed by three dis-
tinct logical phases:
i) prioritisation of the 8 dimensions of analysis;
ii) evaluation of the technologies, thanks to the support 
of 13 quantitative criteria for the complete quantitative 
assessment and the production of a final report;
iii) determination of a concise result, for the final ap-
praisal of the evaluated innovations.
With regards to the first phase, the 8 dimensions com-
posing the framework are prioritized by specific evalu-
ators, in accordance with the VTS-HTA Lombardy Re-
gion model [15]. Thus, the dimensions are prioritised in 
order to show their relative importance through a numer-
ical value, following a rating scale from 1 to 8 (1 = less 
important and 8 = more important), using the evaluators’ 
judgment in order to define which is the most important 
dimension. 
A clarification is needed. The chief of the Department of 
Obstetrics and Gynaecology (who was currently using 
the innovative technology) needed to evaluate all the im-
pact related to the introduction of Colpoceliotomy in the 
ordinary clinical practice, thus requiring the judgement 
of the Strategic Board. The prioritization phase involved 
5 members of the Hospital Authority, acting as evalua-
tors.
The second phase consists of a detailed analysis of the 
dimensions; i) identification of different evaluation sub-
dimensions; ii) attribution to each of them, a three level 
rating score with 1 (less performant), 2 (equal perfor-
mant) and 3 (more performant) was applied, in accord-
ance to the Mitton Model [17].
For the complete technology assessment, developing 
the IMPAQHTA framework, a multi-disciplinary HTA 
team was required: 6 volunteers, with a certified knowl-
edge and skills on HTA, composed an evaluating team 
and produced an unabridged IMPAQHTA report, useful 
for the Strategic Board, to take evidence-based choices 
during the appraisal phase.
The third phase, according to evidence in the literature, 
regarding EVIDEM Core Model and Multi-Criteria De-
cision Analysis, leads to the final synthesis, in order to 
compare the technologies evaluated. The higher the final 
rating is, the more preferable the technology is. This fi-
nal evaluation was conducted by the Strategic Board of 
the reference Hospital, with the inclusion of the Chief of 
Department of Obstetrics and Gynaecology.
Moving on from these premises, the evaluation of the 
above mentioned 8 dimensions was conducted by the 
multi-disciplinary team, with the development of 13 
sub-dimensions using specific operative and quantita-
tive tool (Tab. I).
It is important to clarify that the efficacy dimension was 
not taken into consideration in the present analysis, be-
cause the proposed evaluation was a specific need of the 
Health Authority of reference, thus grounding the as-
sessment on real data referring to the year 2013.
Safety is a relevant dimension to be investigated, one 
that leads to the evaluation of adverse events, mortality 
or morbidity, related to the technologies under assess-
Tab. I. Details of the dimensions and the related sub-dimension of 
the IMPAQHTA model.
Dimensions Sub-dimensions
General relevance
Quality of scientific evidences 
Description of the pathology and the 
related technologies
Safety
Seriousness of Adverse Events (mild, 
moderate or severe adverse events)
Efficacy Efficacy data
Effectiveness Effectiveness data
Economic financial 
Impact
ABC
Health Economic Evaluation
Budget Impact Analysis
Equity Equity data
Legal, social and 
ethic impact
Legal aspects
Social and ethical impact
Organizational 
Impact
Quantitative impact
Qualitative impact 
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ment. In particular, it allows the identification of mild/
moderate/severe adverse events, considering the popula-
tion treated with the technology. Since the lack in litera-
ture of this specific information, safety data were col-
lecting through specific interviews to clinicians, in rela-
tion to their own clinical experience. In particular, safety 
information refer to all the possible consequences on the 
patient, related to the use of the innovative technology, 
in terms of a) seriousness of adverse events; b) invasive-
ness of the procedure; c) safety in its implementation.
Equity, legal and organizational impacts were investi-
gated using specific questionnaires, completed by both 
clinicians and patients, in accordance with the items 
composing the EUnetHTA Core Model. For instance, 
the equity impact aimed at investigating a) access to care 
on a local level; b) access to care for person of a legally 
protected status; c) hospital waiting list improvement 
and d) the invasiveness of the innovative technology. 
The legal and the social impact aimed at evaluating both 
the patients’ satisfaction and the related productivity 
loss. 
Furthermore, the organizational impact had the objec-
tive to define the perception of the clinicians involved 
in the innovative procedure and to quantify all the in-
vestments needed if organizational changes occurred: a) 
additional people; b) additional room; c) training course; 
d) meeting and e) learning time of the implementation 
of the innovation, f) investment in equipment; g) up-
date of the existing equipment; h) impact on the internal 
and the purchasing processes. According to this, all the 
items composing the above mentioned dimensions have 
been evaluated by the multi-disciplinary team (with the 
support of clinicians), with the rating scale proposed by 
Mitton and colleagues in 2011, as previously mentioned.
With regard to the economic and financial dimension, 
the method used for the enhancement of the average cost 
of the two technologies was the Activity Based Costing 
analysis (ABC), which measured the costs and perfor-
mances of each activity. The concept of ABC was first 
defined in 1980 by Cooper and Kaplan [18] and it fo-
cused on the activity useful for the final output of the of-
fered service; in particular, it gives the cost of a specific 
product (in this case, a specific technology), according 
to the activities through the use of cost drivers [19]. The 
process consists of the following stages [18, 20-21]: i) 
activities’ identification; ii) definition of the activities’ 
cost; iii) definition of the activities’ cost drivers; iv) defi-
nition of the cost drivers’ volume; v) definition of a unit 
cost, per cost driver, for each activity and vi) calculation 
of the unit cost per procedure.
Another methodology applied to compare the two tech-
nologies is the Cost-effectiveness analysis (CEA), an 
economic evaluation in which the costs of alternative 
procedures are compared using outcomes measures ex-
pressed in natural units [22]. In order to implement the 
CEA it is necessary to have suitable measures of effec-
tiveness, because this technique expresses health ben-
efits in simple terms, such as years of life gained [23]. 
From a methodological point of view, CEA is divided 
into five stages: i) definition of the program; ii) com-
putation of net costs; iii) computation of net health ef-
fects; iv) application of decision rules; v) sensitivity 
analysis  [23]. This method is often implemented in an 
HTA report in order to obtain a specific effectiveness 
with minimum costs.
Whereas a CEA evaluates both costs and outcomes of 
alternative technologies over a specified time horizon 
in order to estimate their economic efficiency, a Budget 
Impact Analysis (BIA) is based on their affordability. In 
fact, its main purpose is to predict the final consequenc-
es of the adoption and diffusion of a new technology into 
a healthcare system with finite resources [24].
Results
The sample
The analysis was conducted in accordance with the real 
data performed by the Department of Obstetrics and 
Gynaecology of the Health Authority Civil Hospital of 
Legnano, during the year 2013.
In particular, it emerged that 166 women were treated 
for the removal of uterine myomas (Tab. II).
The table above shows that the two populations under 
analysis (118 patients in the arm of colpoceliotomy and 
48 patients in the arm of laparascopy) were comparable 
from both the dimensions and the diameters of the myo-
mas. It could be considered a relevant feature, allowing 
the comparability of the two population and the related 
technologies used in this category of procedure.
Results from the IMPAQHTA model 
implementation
The first step of the HTA is the prioritisation of the di-
mensions, by the chief of the Department and the Strate-
gic Board of the Hospital of reference, involving a total 
of 5 individuals as evaluators. The table below shows 
that the most important variable for the experts is the 
patient’s safety (Tab. III).
The second most relevant dimension is the economic 
and financial impact. When the ABC analysis is imple-
mented, the technologies are perfectly super-imposable 
in terms of the process’ description; however, the spe-
Tab. II. Description of the sample under assessment.
Colpoceliotomy Laparoscopy P-value
N. of patients 118 48
Mean age [years] 41 39 > 0.005
Length of the 
procedure [min]
85 80 > 0.005
Myoma 
diameters [cm]
7 6 > 0.005
Myoma 
dimensions [gr]
100 200 0.01
Length of 
hospitalization
3 5 0.000
Adverse events 1,60% 6% 0.000
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cific and related operative phases of the intervention are 
different (Tab. IV).
The table above shows the differences, between each 
phase, in terms of costs and impact. It emerges that 
laparoscopy absorbs economic resources for a total of € 
1,789.42, whereas colpoceliotomy a total of €1,336.15, 
allowing a €453.72 saving for each surgery. This dif-
ference may be explained by the expensive instruments 
used for laparoscopy.
The CEA was calculated as the “ratio” between the unit 
cost per patient related to the two compared technologies 
(derived from the previously conducted ABC Analysis) 
and the effectiveness data. The effectiveness data is de-
fined as the percentage of “non-complications surgery”. 
It emerges that in the colpoceliotomy arm only 1.60% of 
patients reported problems during surgery. 
On the contrary, in the laparoscopy arm 4% of patients 
reported the onset of mild and moderate adverse events. 
As previously mentioned, the effectiveness data used 
for the CEA have been collected from an observational 
study involving 166 patients in total (see Table II)
In accordance with the real data related to the year 2013, 
Table V shows that the innovative procedure achieved 
a higher cost-effectiveness value if compared with the 
gold standard technology. Colpoceliotomy, on the basis 
of an increase in the effectiveness data, leads to a de-
crease of total costs, thus being defined as the dominant 
strategy.
In the BIA, two scenarios are considered: the first one 
calculates the annual cost of 118 laparoscopy surgeries 
and 48 standard procedures, taking into account what 
actually happened in the year 2013 within the reference 
Health Authorities; the second one estimates the annual 
cost of 166 surgeries, if done with the standard technol-
ogy (it could be considered as the “baseline” scenario). 
According to this scenario, the BIA, with the inclusion 
of both the results deriving from the activity based cost-
ing approach, and the organisational investment needed, 
leads to an overall significant financial and economic 
saving for the Health Authority of reference, in case 
of implementation of colpoceliotomy procedure in the 
clinical practice (with regards to the year 2013). 
An economic saving of € 48,955.06 emerged from the 
evidence, in the first scenario: the data confirmed that 
colpoceliotomy could be introduced in the clinical prac-
tice of the referred hospital. This difference takes into 
account also the training costs required by the introduc-
tion of colpoceliotomy.
This analysis was implemented over a 12-month period 
due to the fact that the present health technology evalu-
ation was requested by the Strategic Management Board 
Tab. III. Prioritisation.
Dimensions
Evaluators Total Normalisation
# 1 # 2 # 3 # 4 # 5
Safety 3 1 1 1 2 1 0.222
Economic and financial 
impact
1 2 3 3 1 2 0.194
Effectiveness 2 5 4 5 3 3 0.167
Organisational impact 5 3 5 2 5 4 0.139
Efficacy 7 7 2 4 4 5 0.111
General relevance 6 6 6 6 6 6 0.083
Equity 4 8 7 7 7 7 0.056
Social and ethical impact 8 4 8 8 8 8 0.028
Tab. IV. ABC analysis.
Phases Laparoscopy Colpoceliotomy
Pre-Hospitalisation 305.08 € 17% 305.08 € 23%
Admission 65.62 € 4% 65.62 € 5%
Pre-Surgery 
Recovery 
38.93 € 2% 38.93 € 3%
Surgery 1,089.64 € 61% 636.37 € 48%
Post-Surgery 201.83 € 11% 201.83 € 15%
Discharge 88.33 € 5% 88.83 € 7%
Total 1,789.42 € 100% 1,336.15 € 100%
Tab. V. Cost-effectiveness and Budget Impact Analysis.
Cost-Effectiveness Value CCT STD
ABC Analysis  €1,336.15  €1,789.42 
Effectiveness data 98.40% 94%
CEV 1,357.87 1,903.64 
Budget Impact Analysis CCT STD
ABC Analysis  €1,336.15 €1,789.42 
# surgery per year 118 48
Surgery cost per year  € 243,557.30 € 297,043.55 
Further Training cost  €3,870.00  
   € 660.80  
Total Training cost  €4,530.80 
BIA  €248,088.10 €297,043.55 
∆ BIA -€48,955.45 €/year
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of the Hospital Authority, and the financial period of ref-
erence for the budget was equal to 12 months.
Additional training courses are relevant from an or-
ganizational point of view. In fact, clinicians have to be 
trained in order to implement the innovative procedure.
The figure shows that colpoceliotomy is preferable from 
an organizational point of view. A clarification is need: 
for a proper reading of the picture, it is important to take 
into consideration the two areas (the wider the area is, 
the more preferable the technology is).
However, specific training courses are needed for cli-
nicians, scrub nurses and support staff for learning the 
correct procedure for colpoceliotomy, in terms of i) ad-
equate preparation of the women undergoing the inter-
vention, ii) proper provision of all the instruments re-
quired and iii) correct implementation of the innovative 
technology.
In particular, it emerged that in the specific setting under 
assessment, 2 surgeons, 3 scrub nurses and 5 health pro-
fessionals needed to attend a 20-hours training course.
With respect to the last phase of the IMPAQHTA frame-
work implementation, it is important to determine a final 
score, both for laparoscopy and colpoceliotomy, useful 
for an evidence-based decision-making appraisal phase. 
It is relevant to specify the sub-criteria of each evaluated 
dimension, starting from the prioritisation shown in Ta-
ble I. Sub-criteria are detailed in order to appoint a basis 
score for each of them.
The following table shows the final score of the present 
comparative study, assigned by all the 5 evaluators that 
have been involved in the prioritization phase (Tab. VI)
In this view, the chief of the Department of Obstetrics 
and Gynaecology and the Strategic Board assigned (in 
columns three and four) a rating score for each sub-
criteria, taking into account all the possible differences 
related to the two technologies under assessment. In col-
umn five and in the final row defining each dimension, 
the maximum total achievable score is reported.
These data allow the calculation of the effect of each 
sub-dimension through a ratio between the maximum 
achievable total score and the established total score.
Finally, it is useful to show the sum of the normalised 
scores per each technology (normalized score x normal-
ized prioritization), resulting a total score for colpoceli-
otomy and a total score for the standard procedure. The 
table shows that colpoceliotomy achieves a higher score 
than laparoscopy (0.56 vs 0.44).
Discussion
As shown in Table VI, colpoceliotomy achieves a high-
er score than laparoscopy. The innovative technology 
presents a lower annual cost and it brings significant 
economic savings for health care organisations. It is 
relevant to note the importance of an appropriate and 
rational implementation of the available technologies, in 
order to achieve maximum benefits with minimal costs.
However, the introduction of a new technology affects 
the Health Authority of reference from an organizational 
point of view, requiring coaching and training courses 
for the persons involved in the procedure (as mentioned 
in the previous section). Then, it is necessary to have 
frequent meetings aimed at communicating the changes 
introduced by the new technical surgery in the whole 
organization.
The adoption of colpoceliotomy does not, however, re-
quire a purchase of new surgical instruments or equip-
ment. Therefore, the innovative technology could lead 
to an economic saving due to the lack of need for ex-
pensive instruments, such as Trocar. The new procedure 
also allows a saving of time with some activities, such 
as the purchase or the maintenance of equipment; this 
may result in a positive impact on the internal process of 
gynaecology units and on health workers’ safety.
If colpoceliotomy were inserted in the clinical setting, 
it would have a positive impact also on the access to 
care, thus positively affecting the equity dimension 
(average score equal to 2.2). In fact, the innovative pro-
cedure would enlarge the treated “target” population, 
including persons of a legally protected status; thanks 
to the use of natural orifices, colpoceliotomy is less 
invasive and specific physical conditions of eligibility 
are not required.
In addition, colpoceliotomy has a relevant social im-
pact on a patient’s life due to a shorter hospitalisa-
tion; this means that patients may return to their daily 
life and work sooner, thus reducing productivity loss. 
From the present analysis, it emerged that the aver-
age score declared by the expert for the social dimen-
sion is equal to 2.5 for colpoceliotomy; the innovative 
technology could improve the patient’s autonomy af-
ter the procedure. 
However, there is a disadvantage in the implementa-
tion of colpoceliotomy: it requires an accurate manual 
ability, which implies a longer learning time of the new 
surgical procedure, thus needing coaching and training 
periods. This has been reflected in the evaluation of the 
Fig. 1. Organizational impact.
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organizational impact (see Fig. 1): the items related to 
training course needed for colpoceliotmy achieved a 
lower score than the standard procedure. The present 
feature has a substantial impact only on a short term 
period, because training courses required only 20 hours 
for person. In general, it emerges that the introduction 
of colpoceliotmy has a positive organizational impact, 
achieving an average score equal to 2.50.
Although an HTA study is a useful tool for decision 
makers, who are involved every day in many different 
strategic and tactical decisions  [25], it is not the only 
one. In fact, the results and evaluation of an HTA are 
relevant to decision making only if they are aligned with 
the mission of the health care organization.
Conclusions
Colpoceliotomy is an alternative technique to laparos-
copy, the latter being the standard method used for the 
treatment and removal of uterine myomas. At present, 
colpoceliotomy is still uncommon because it requires a 
high knowledge of the anatomy of female genitalia (in 
particular the vaginal canal), high experience and manu-
al ability. Furthermore, the innovative procedure meets 
institutional constraints that limit its implementation.
In the present study, an HTA evaluation was made, which 
compared the use of traditional laparoscopy and colpoce-
liotomy for the removal of uterine myomas. The results 
showed that the innovative technology is more advanta-
Tab. VI. HTA comparative study.
Basis score
Normalsed 
score
Final score
Dimensions Sub – dimensions CCT STD TOT Incidence CCT STD
Normalized 
prioritization
CCT STD
Safety   2 2 6 1.5 0.5 0.5      
    4     0.5 0.5 0.22 0.11 0.11
Economic and 
financial impact
Activity Bases Costing 
Analysis
2 1 6 0.7 0.2 0.1      
Cost-effectiveness 
Analysis
2 1 6 0.7 0.2 0.1  
Budget Impact Analysis 2 1 6 0.7 0.2 0.1  
    9     0.7 0.3 0.19 0.13 0.06
Effectiveness   2 1 6 2.0 0.7 0.3      
    3     0.7 0.3 0.17 0.11 0.06
Organisational 
impact
Quantitative Impact 2 1 6 0.9 0.3 0.1      
Qualitative Impact 2 2 6 0.9 0.3 0.3  
    7     0.6 0.4 0.14 0.08 0.06
Efficacy   2 2 6 1.5 0.5 0.5      
    4     0.5 0.5 0.11 0.06 0.06
General relevance
Consistency of 
evidence
1 3 6 0.3 0.0 0.1      
Description of 
technology and 
comparator
1 2 6 0.3 0.0 0.1  
Safety of the new 
technology and 
comparator 
2 2 6 0.3 0.1 0.1  
Target Population 2 1 6 0.3 0.1 0.0  
Consistency of the 
objectives with the 
adopted strategy
2 2 6 0.3 0.1 0.1  
Potential advantaged 
areas
2 2 6 0.3 0.1 0.1  
    22     0.5 0.5 0.08 0.04 0.05
Equity   2 3 6 1.2 0.4 0.6      
    5     0.4 0.6 0.06 0.02 0.03
Social and ethical 
impact 
Ethical Impact 3 2 6 0.6 0.3 0.2      
Social Impact 3 2 6 0.6 0.3 0.2  
    10     0.6 0.4 0.03 0.02 0.01
Results 0.56 0.44
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geous in terms of invasiveness and shorter surgery time; 
thus, this procedure is low-time consuming [26].
The study highlights both the social and the financial 
impact of colpoceliotomy, considering also the organi-
sational impact on health care companies, represented 
by the introduction of coaching and training courses 
both for the medical staff and the support personnel in-
volved in the surgery.
Data show that the new procedure is safe, and that it pro-
vides both short and long term benefits in terms of the 
savings in the purchase and maintenance of machinery.
The innovative technology leads to a significant reduc-
tion in adverse events, invasiveness, duration of surgery 
and post-operative hospitalization.
Considering the economic and financial perspective, the 
new procedure would lead to a substantial reduction of 
costs related to the absence of sophisticated equipment, 
as required by laparoscopy, and to a smaller number of 
personnel involved.
Therefore, colpoceliotomy may be considered a valu-
able tool in reducing costs regarding the surgical treat-
ment for uterine myomas.
In conclusion, although the present study highlights its 
technical superiority; that is, the advantages it ensures 
over prior or existing technologies  [27], a further ran-
domised study is suggested in order to confirm colpoce-
liotomy’s benefits achieved in the present study.
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